BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33591334)

  • 1. Immortal Time Bias in Observational Studies.
    Yadav K; Lewis RJ
    JAMA; 2021 Feb; 325(7):686-687. PubMed ID: 33591334
    [No Abstract]   [Full Text] [Related]  

  • 2. Early menopause and cardiovascular risk: directionality matters.
    Nudy M; Cooper JL; Schnatz PF
    Menopause; 2023 Jun; 30(6):569-570. PubMed ID: 37220770
    [No Abstract]   [Full Text] [Related]  

  • 3. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias?
    Suissa S
    Diabetes Care; 2018 Jan; 41(1):6-10. PubMed ID: 29263192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early age at natural menopause and risk of cardiovascular and all-cause mortality: A meta-analysis of prospective observational studies.
    Gong D; Sun J; Zhou Y; Zou C; Fan Y
    Int J Cardiol; 2016 Jan; 203():115-9. PubMed ID: 26512821
    [No Abstract]   [Full Text] [Related]  

  • 5. Premature menopause increases cardiovascular risk.
    Archer DF
    Climacteric; 2009; 12 Suppl 1():26-31. PubMed ID: 19811237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When observational studies can give wrong answers: the potential of immortal time bias.
    Dekkers OM; Groenwold RHH
    Eur J Endocrinol; 2021 Jan; 184(1):E1-E4. PubMed ID: 33112276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ITT for observational data: worst of both worlds?
    Stampfer MJ
    Epidemiology; 2008 Nov; 19(6):783-4; discussion 789-93. PubMed ID: 18813017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immortal time bias in drug safety cohort studies: spontaneous abortion following nonsteroidal antiinflammatory drug exposure.
    Daniel S; Koren G; Lunenfeld E; Levy A
    Am J Obstet Gynecol; 2015 Mar; 212(3):307.e1-6. PubMed ID: 25265406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premenopausal hysterectomy and risk of cardiovascular disease.
    Punnonen R; Ikäläinen M; Seppälä E
    Lancet; 1987 May; 1(8542):1139. PubMed ID: 2883456
    [No Abstract]   [Full Text] [Related]  

  • 10. Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses.
    Hernán MA; Sauer BC; Hernández-Díaz S; Platt R; Shrier I
    J Clin Epidemiol; 2016 Nov; 79():70-75. PubMed ID: 27237061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Example of How Immortal Time Bias Can Reverse the Results of an Observational Study.
    Airaksinen J; Pentti J; Suominen S; Vahtera J; Kivimäki M
    Epidemiology; 2020 Mar; 31(2):e19-e20. PubMed ID: 31567749
    [No Abstract]   [Full Text] [Related]  

  • 12. Understanding and Avoiding Immortal-Time Bias in Gastrointestinal Observational Research.
    Targownik LE; Suissa S
    Am J Gastroenterol; 2015 Dec; 110(12):1647-50. PubMed ID: 26323186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premature menopause and cardiovascular disease: can we blame estrogen?
    Torbati T; Shufelt C; Wei J; Noel Bairey Merz C
    Eur Heart J; 2022 Oct; 43(40):4158-4160. PubMed ID: 36239222
    [No Abstract]   [Full Text] [Related]  

  • 14. "Resuscitation time bias"-A unique challenge for observational cardiac arrest research.
    Andersen LW; Grossestreuer AV; Donnino MW
    Resuscitation; 2018 Apr; 125():79-82. PubMed ID: 29425975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies.
    Karim ME; Gustafson P; Petkau J; Tremlett H;
    Am J Epidemiol; 2016 Aug; 184(4):325-35. PubMed ID: 27455963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-Blockers in COPD: A Methodological Review of the Observational Studies.
    Suissa S; Ernst P
    COPD; 2018 Oct; 15(5):520-525. PubMed ID: 30822238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of immortal person-time and time scale in comparative effectiveness research for medical devices: a case for implantable cardioverter-defibrillators.
    Mi X; Hammill BG; Curtis LH; Greiner MA; Setoguchi S
    J Clin Epidemiol; 2013 Aug; 66(8 Suppl):S138-44. PubMed ID: 23849148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of cardiovascular events in early menopause: a possible role for hormone replacement therapy.
    Antonicelli R; Olivieri F; Morichi V; Urbani E; Mais V
    Int J Cardiol; 2008 Nov; 130(2):140-6. PubMed ID: 18617278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early menopause and subsequent cardiovascular disease.
    Bertone-Johnson ER; Manson JE
    Menopause; 2015 Jan; 22(1):1-3. PubMed ID: 25490113
    [No Abstract]   [Full Text] [Related]  

  • 20. [Estrogens and cardiovascular risk in postmenopausal women. I. Epidemiologic data].
    Sitruk-Ware R
    Presse Med; 1990 Jun; 19(26):1230-5. PubMed ID: 2142774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.